Kazuki Tanimoto - Publications

Comparison of quantitative PCR values and antigenemia for CMV monitoring in hematopoietic cell transplant recipients.

Journal: International journal of hematology

Published: July 02, 2025

Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study.

Journal: British journal of haematology

Published: April 18, 2025

Clinical Impact of Continuous Dasatinib Administration on the Prognosis of Patients With BCR::ABL1 Acute Lymphoblastic Leukemia: Result of the Prospective MRD2014 Study Conducted by Fukuoka Blood and Marrow Transplantation Group (FBMTG).

Journal: European journal of haematology

Published: February 06, 2025

Adverse events during preoperative autologous blood donation and its usage in obstetrical patients: A multicenter, retrospective survey in Japan.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: November 05, 2024

Augmented use of L-asparaginase markedly improves AYA ALL outcomes: FBMTG prospective MRD2014 study.

Journal: Blood neoplasia

Published: May 24, 2024

Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study.

Journal: American journal of hematology

Published: August 16, 2023

Impact of a third dose of anti-SARS-CoV-2 vaccine in hematopoietic cell transplant recipients: A Japanese multicenter observational study.

Journal: Vaccine

Published: July 18, 2023

A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.

Journal: Annals of hematology

Published: April 06, 2023

A case in which baricitinib was effective for both rheumatoid arthritis and essential thrombocythemia.

Journal: Modern rheumatology case reports

Published: September 15, 2022

Predictors of impaired antibody response after SARS-CoV-2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study.

Journal: American journal of hematology

Published: August 16, 2022

Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group study.

Journal: British journal of haematology

Published: July 12, 2022

A Novel Hematopoietic Progenitor Cell Mobilization Regimen Comprising Bortezomib, G-CSF, and Preemptive Plerixafor for Multiple Myeloma.

Journal: Blood cell therapy

Published: May 25, 2020